Related Experiment Video
Updated: Jun 14, 2026

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism
Hong Lan1, Ling Pang, Marsha M Smith
1Cardiovascular and Metabolic Disease Research, Merck Research Laboratories, Kenilworth, New Jersey 0703, USA.
Abstract:
Proprotein convertase subtilisin/kexin type 9 (PCSK9) induces degradation of low-density lipoprotein receptor (LDLR) in the liver. It is being pursued as a therapeutic target for LDL-cholesterol reduction. Earlier genome-wide gene expression studies showed that PCSK9 over-expression in HepG2 cells resulted in up-regulation of genes in cholesterol biosynthesis and down-regulation of genes in stress response pathways; however, it was not known whether these changes were directly regulated by PCSK9 or were secondary to PCSK9-induced changes to the intracellular environment. In order to further understand the biological function of PCSK9 we treated HepG2 cells with purified recombinant wild type (WT) and D374Y gain-of-function PCSK9 proteins for 8, 24, and 48 h, and used microarray analysis to identify genome-wide expression changes and pathways. These results were compared to the changes induced by culturing HepG2 cells in cholesterol-free medium, mimicking the intracellular environment of cholesterol starvation. We determined that PCSK9-induced up-regulation of cholesterol biosynthesis genes resulted from intracellular cholesterol starvation. In addition, we identified novel pathways that are presumably regulated by PCSK9 and are independent of its effects on cholesterol uptake. These pathways included "protein ubiquitination," "xenobiotic metabolism," "cell cycle," and "inflammation and stress response." Our results indicate that PCSK9 affects metabolic pathways beyond cholesterol metabolism in HepG2 cells.
Insights
Proprotein convertase subtilisin/kexin type 9 (PCSK9) influences cholesterol metabolism by upregulating cholesterol biosynthesis genes due to intracellular cholesterol starvation. PCSK9 also impacts other pathways, including protein ubiquitination and xenobiotic metabolism, independent of cholesterol uptake.
Area of Science:
- Molecular Biology
- Biochemistry
- Genomics
Background:
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) targets the low-density lipoprotein receptor (LDLR) for degradation, making it a therapeutic target for lowering LDL-cholesterol.
- Previous studies indicated PCSK9 overexpression in HepG2 cells altered cholesterol biosynthesis and stress response genes, but the direct role of PCSK9 versus intracellular environment changes was unclear.
Purpose of the Study:
- To elucidate the direct biological functions of PCSK9 beyond its known role in LDLR degradation.
- To differentiate PCSK9-mediated gene expression changes from those induced by intracellular cholesterol levels.
Main Methods:
- HepG2 cells were treated with wild-type and gain-of-function PCSK9 proteins for varying durations (8, 24, 48 hours).
- Microarray analysis was employed to identify genome-wide expression changes and affected pathways.
- Gene expression profiles were compared to cells cultured in cholesterol-free medium to simulate cholesterol starvation.
Main Results:
- PCSK9-induced upregulation of cholesterol biosynthesis genes was attributed to intracellular cholesterol starvation, not direct PCSK9 regulation.
- Novel PCSK9-regulated pathways independent of cholesterol uptake were identified, including protein ubiquitination, xenobiotic metabolism, cell cycle, and inflammation/stress response.
- PCSK9 demonstrated a broader impact on metabolic pathways in HepG2 cells than previously recognized.
Conclusions:
- PCSK9's effect on cholesterol biosynthesis genes is primarily a consequence of intracellular cholesterol starvation.
- PCSK9 regulates distinct cellular pathways, including protein ubiquitination, xenobiotic metabolism, cell cycle, and stress responses, independent of its cholesterol-lowering mechanism.
- PCSK9 plays a multifaceted role in cellular metabolism extending beyond cholesterol homeostasis.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Cell Specific Gene Expression
Regulation of Nuclear Protein Sorting
cAMP-dependent Protein Kinase Pathways
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Cholesterol: Significance and Regulation
Considering cholesterol and...
